Strategic Corporate Venture Capital
M Ventures is the strategic corporate venture capital fund of our company, with a dual remit of strategic and financial returns. In 2021, we increased the funds available for investment by an additional Eur 600M to enable more and larger investments across our two investment areas of Biotechnology and Technology.
We help, initiate, drive innovation by supporting entrepreneurs through hands-on support and equity investments in fields that could impact our companys mid to long-term business interests.
“We have the privilege to be able to work with entrepreneurs globally to enable them to turn their cutting edge science into first in class products that improve human well being. We are not just a finance provider but a true hands-on partner to our portfolio companies and management teams.”
Calling all industry disruptors, dreamers and innovators
We help, initiate, drive innovation by supporting entrepreneurs through hands-on support and equity investments in fields that could impact our company mid to long-term business interests. Between our Netherlands headquarters and offices in Germany, Israel and USA, M Ventures invests across four fields: Healthcare + Life Sciences, Electronics + Frontier Technologies and Sustainability led by our experienced Biotech and Technology investment teams respectively.
Each M Ventures team facilitates their own field’s seed-stage company creation, early-stage syndicated investments, and Merck KGaA, Darmstadt, Germany spin-off creation and funding in close alignment with sector strategies. M Ventures also participates in innovation focused internal Merck KGaA, Darmstadt, Germany activities and business development teams bringing in external insights into their decision making. M Ventures is formally separated from our company businesses by an information Firewall Wall that enables M Ventures to invest with a dual outlook on financial and strategic returns, and to ensure neither Merck KGaA, Darmstadt, Germany nor M Ventures’ investee companies are at risk of information contamination.
“M Ventures’ world class team has successfully built a significant portfolio of innovative companies that align with future strategy of our businesses. We additionally validated our dual foci as a strategic and financial Corporate VC with several of our companies establishing collaborations with Merck KGaA, Darmstadt, Germany."
From innovation to success
We take an active role in our portfolio companies and team them up with entrepreneurs and co-investors to help them translate innovation into commercial success. Where necessary, team members will take on operational roles, such as interim CEO, Chairperson of the board, CBO or CFO, until the new company is ready to be self-sufficient. M Ventures offers the benefits of an active and experienced early-stage investor together with access to the research, development and commercial resources of a leading science and technology company.